Costantini, A.; Takam Kamga, P.; Julie, C.; Corjon, A.; Dumenil, C.; Dumoulin, J.; Ouaknine, J.; Giraud, V.; Chinet, T.; Rottman, M.;
et al. Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers 2021, 13, 97.
https://doi.org/10.3390/cancers13010097
AMA Style
Costantini A, Takam Kamga P, Julie C, Corjon A, Dumenil C, Dumoulin J, Ouaknine J, Giraud V, Chinet T, Rottman M,
et al. Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers. 2021; 13(1):97.
https://doi.org/10.3390/cancers13010097
Chicago/Turabian Style
Costantini, Adrien, Paul Takam Kamga, Catherine Julie, Alexandre Corjon, Coraline Dumenil, Jennifer Dumoulin, Julia Ouaknine, Violaine Giraud, Thierry Chinet, Martin Rottman,
and et al. 2021. "Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors" Cancers 13, no. 1: 97.
https://doi.org/10.3390/cancers13010097
APA Style
Costantini, A., Takam Kamga, P., Julie, C., Corjon, A., Dumenil, C., Dumoulin, J., Ouaknine, J., Giraud, V., Chinet, T., Rottman, M., Emile, J.-F., & Giroux Leprieur, E.
(2021). Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers, 13(1), 97.
https://doi.org/10.3390/cancers13010097